| 1/11 | US=17 / Mama Chagas CR. Câncer de mama - etiologia, fatores de risco e história natural. In: Franco JM. Mastologia: formação do especialista. São Paulo: Atheneu, 1999. p. 133-51. ETIOLOGIA; FATORES DE RISCO; HISTORIA FAMILIAR; TIPOS DE HEREDITARIEDADE; CANCER DE MAMA ANTERIOR; DOENCAS BENIGNAS DAS MAMAS; FATORES ENDOCRINOS; FATORES ENDOCRINOS ENDOGENOS; DIETA; ALCOOL; PESO CORPORAL; CRESCIMENTO DO TUMOR; FATORES DE CRESCIMENTO; ONCOGENES; PROPAGACAO POR VIA DIRETA; ANGIOGENESE; PROPAGACAO LINFATICA; LINFATICOS DA GLANDULA MAMARIA; PROPAGACAO POR VIA VASCULAR; IMPORTANCIA DO COMPROMETIMENTO AXILAR; TAXA DE CRESCIMENTO TUMORAL |
| 2/11 | US=9 / Urologia Schally AV, Block NL. Luteinizing hormone-releasing hormone and its agonistic, antagonistic, and targeted cytotoxic analogs in prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 27-39. ISBN 978-1-60327-831-7. CANCER DE PROSTATA; SECRECAO DE LH; SECRECAO FSH; ESTEROIDES SEXUAIS; GONADOTROFINA; CASTRACAO QUIMICA; EFEITOS ANTICANCERIGENOS; CRESCIMENTO DO TUMOR; PROLIFERACAO CELULAR; RECEPTOR LHRH |
| 3/11 | US=33 / Câncer Mimeault M, Batra SK. Critical roles of tumorigenic and migrating cancer stem/progenitor cells in cancer progression and their therapeutic implications. In: Bagley RG, Teicher BA. Stem cells and cancer. New York: Humana Press, 2009. p. 287-308. ISBN 978-1-60327-932-1. TRONCO DO CANCER; CELULAS PROGENITORAS; MICROAMBIENTE ESTROMAL; TRANSICAO EPITELIAL MESENQUIMAL; CRESCIMENTO DO TUMOR; TUMORIGENICOS; CANCER MIGRATORIAS ESTAMINAIS; INVASAO; METASTASE; TERAPIAS COM ALVO; PROGENITORAS DE CELULAS; PROGRESSAO DO CANCER |
| 4/11 | US=8 / Laboratório Gerson SL, Bhalla KN, Grant S, Natarajan K, Creger RJ, DeRemer D. Pharmacology and molecular mechanisms of antineoplastic agents for hematologic malignancies. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 839-98. ISBN 978-0-443-06715-0. FARMACOLOGIA; MECANISMOS MOLECULARES; AGENTES ANTINEOPLASICOS; DOENCAS HEMATOLOGICAS; CINETICA CELULAR; CICLO CELULAR; CRESCIMENTO DO TUMOR; AGENTES QUIMIOTERAPEUTICOS; APOPTOSE; RESISTENCIA A DROGAS; AGENTES ALQUILANTES; AGENTES ANTIMICROTUBULOS; ANTIMETABOLITOS; INIBIDORES DA TOPOISOMERASE; ANALOGOS DE PLATINA |
| 5/11 | US=50 / Câncer Ferrara N. Vascular endothelial growth factor: basic biology and clinical application. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 11-21. ISBN 978-1-60327-086-1. FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; FACTOR DE CRESCIMENTO; ENDOTELIAL VASCULAR; ENDOTELIO; ANGIOGENESE; TIROSINA-QUINASES; CRESCIMENTO DO TUMOR |
| 6/11 | US=49-F / Câncer Jiang BH,Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2009. p. 19-65. ISBN 978-0-12-3744371. PI3K/PTEN; SINALIZACAO NA ANGIOGENESE; SINALIZACAO TUMORIGENESE; ANGIOGENESE REGULADA POR VEGF; ABERRACOES GENETICAS DE PI3K, PTEN E AKT EM CANCER; PAPEIS DE PI3K E AKT NA REGULACAO DA ANGIOGENESE; CRESCIMENTO DO TUMOR; METASTASE DE TUMOR; ANGIOGENESE TUMORAL |
| 7/11 | US=9-A / Ginecologia Markman M. Chemotherapy. In: Berek JS, Hacker NF. Berek and Hacker's gynecologic oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2009. p. 57-82. ISBN 978-0-7817-9512-8. ONCOLOGIA GINECOLOGICA; QUIMIOTERAPIA; CRESCIMENTO DO TUMOR; FATORES BIOLOGICOS; FATORES FARMACOLOGICOS; COMBINACAO QUIMIOTERAPICA; DROGAS ANTINEOPLASICAS |
| 8/11 | US=60 / Enfermagem Dougherty L, Bailey C. Chemotherapy. In: Corner J, Bailey C. Cancer nursing: care in context. 2nd ed. St. Louis: Blackwell Science, 2008. p. 267-316. ISBN 978-1-4051-2253-5. CANCER; QUIMIOTERAPIA; CICLO CELULAR; CRESCIMENTO DO TUMOR; FARMACOLOGIA; DROGAS CITOTOXICAS; VIAS DE ADMINISTRACAO; QUIMIOTERAPIA AMBULATORIAL INFUSIONAL; AGENTES ANTI-CANCERIGENOS |
| 9/11 | US=111-A / Câncer Riedel H. Models for tumour growth and differentiation. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 954-69. ISBN 978-0-470-01852-1. |
| 10/11 | US=58 / Biol/Mol McConville P, Elliott WL, Kreger A, Lister R, Moody JB, Trachet E, Urban F, Leopold WR. Preclinical models of tumor growth and response. In: Shields AF, Price P. In vivo imaging of cancer therapy. New Jersey: Humana Press, 2007. p. 13-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-633-7. CRESCIMENTO DO TUMOR; RESPOSTA DO TUMOR; TIPOS DE MODELOS DE TUMORES; ENDPOINTS; MEDICOES; CARGA TUMORAL |
| 11/11 | US=68 / Biol/Mol Baroni TE, Lastro MT, Ranganathan AC, Tenenbaum SA, Conklin DS, Aguirre-Ghiso JA. Ribonomic and short hairpin RNA gene silencing methods to explore functional gene programs associated with tumor growth arrest. In: Fisher PB. Cancer genomics and proteomics: methods and protocols. New Jersey: Humana Press, 2007. p. 227-44. (Methods in Molecular Biology, 383) ISBN 978-1-58829-504-0. HAIRPIN; RNA; METODOS DE SILENCIAMENTO GENICO; PROGRAMAS DE GENES FUNCIONAIS; CRESCIMENTO DO TUMOR; PERFIL DE EXPRESSAO; SILENCIAMENTO GENICO; IMUNOPRECIPITACAO; PROTEINA RNA-BINDING; DORMENCIA TUMOR |